What is the association of tirzepatide vs glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment with all-cause mortality and adverse cardiovascular or kidney events in US patients with type 2 diabetes? Here, GLP1R is linked to type 2 diabetes mellitus.